AbbVie Inc. (ABBV)
NYSE • Healthcare
April 2, 2026 at 20:00 UTC
About AbbVie Inc.
AbbVie Inc. is a biopharmaceutical company that researches, develops, and markets therapies across immunology, oncology, neuroscience, and other therapeutic areas. The company is known for both specialty medicines and a pipeline of investigational drugs designed to address chronic and complex diseases. Its research strategy emphasizes biologics, small molecules, and targeted therapies supported by clinical trials and global partnerships. With worldwide operations, AbbVie integrates advanced science with commercial scale to deliver healthcare solutions. Positioned within the healthcare sector, the company reflects the growing role of biotechnology in modern medicine.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
AbbVie Inc.'s Technical Indicators Summary
ABBV's technicals lean bearish as price sits under several medium-term averages and volume dynamics lack support. Short-term averages are constructive, but the broader moving-average structure shows resistance and VWAP plus classic pivots are above the market, adding overhead pressure. Momentum readings are mixed and ADX is subdued, while OBV is negative and volatility is moderate, implying limited bullish conviction. Technical takeaway: Bearish — medium-term moving-average resistance and weak volume favor a cautious, negative bias.
| Indicator | Value |
|---|---|
RSI (14) | 46.78 |
Stochastic %K (14, 3, 3) | 49.54 |
CCI (20) | -6.21 |
WPR (14) | -51.06 |
Momentum (10) | 6.59 |
MFI | 36.87 |
MACD Level (12, 26) | -3.58 |
Bollinger Bands | $198.00 - $235.39 |
ATR (14) | $5.72 (2.66%) |
ADX (14) | 21.93 |
OBV | 8,684,668 |
VWAP | $215.69 |
Classic Pivot Point | $217.17 |
Fibonacci Pivot Point | $217.17 |
Simple Moving Averages | $209.47 - $223.93(5 indicators) |
Exponential Moving Averages | $212.60 - $220.54(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
End-of-day pricing shows ABBV still under yesterday’s 214.98, with the -2.86% gap down leaving it at 208.84. End-of-day sector performance was slightly negative (-0.62%), mildly offsetting stock-specific strength. ABBV slides as proposed US tariffs on branded drugs threaten margins and growth prospects.
Price Change
from $208.29 close
+$0.53
Trading Volume
Below avg (8.5M)
5M
vs S&P 500 Today
Strong Underperformance
-6.25%
52-Week Position
Mid-range
55.3%
Updated: April 3, 2026 at 20:09 UTC
Quote Summary
ABBV Headlines
Valuation Shifts In Major Healthcare Stocks
March 25, 2026
REGENXBIO maps 2026 gene therapy milestones
March 6, 2026
Boston Scientific, AbbVie, NOG Lead Busy Corporate Day
February 23, 2026
Christmas Eve early close shapes U.S. markets
December 24, 2025